Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

PLD is an effective and safer alternative for treating breast cancer.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Terbinafine quickly builds up in skin and hair, staying effective for over 3 weeks.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Clascoterone may be a promising treatment for hair loss.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Glibenclamide slows breast cancer cell growth by stopping cell division.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Baricitinib shows promise in treating severe hair loss.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

A new compound that could treat various androgen-related conditions was created and analyzed.

Calcipotriol does not improve the effectiveness of squaric acid dibutylester in treating alopecia areata.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Sorafenib can cause rare skin reactions, but treatment can continue with additional care.

Sonidegib and vismodegib have different side effects and reporting patterns.

Afatinib often causes skin problems that need proactive management.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.